153 related articles for article (PubMed ID: 36194187)
21. Relamorelin Reduces Vomiting Frequency and Severity and Accelerates Gastric Emptying in Adults With Diabetic Gastroparesis.
Lembo A; Camilleri M; McCallum R; Sastre R; Breton C; Spence S; White J; Currie M; Gottesdiener K; Stoner E;
Gastroenterology; 2016 Jul; 151(1):87-96.e6. PubMed ID: 27055601
[TBL] [Abstract][Full Text] [Related]
22. Botulinum toxin (Botox, Dysport, and Myobloc): pharmacology 101.
Wynn RL
Gen Dent; 2011; 59(2):88-90. PubMed ID: 21903516
[No Abstract] [Full Text] [Related]
23. Endoscopic treatment of gastroparesis.
McCarty TR; Rustagi T
World J Gastroenterol; 2015 Jun; 21(22):6842-9. PubMed ID: 26078560
[TBL] [Abstract][Full Text] [Related]
24. Botulinum toxin type A and type B for sialorrhoea in Parkinson's disease: a case for switching therapy?
Santamato A; Panza F; Solfrizzi V; Frisardi V; Ranieri M; Fiore P
J Rehabil Med; 2008 Nov; 40(10):882-3. PubMed ID: 19242630
[No Abstract] [Full Text] [Related]
25. Botulinum toxin type A vs type B for axillary hyperhidrosis in a case series of patients observed for 6 months.
Frasson E; Brigo F; Acler M; Didonè G; Vicentini S; Bertolasi L
Arch Dermatol; 2011 Jan; 147(1):122-3. PubMed ID: 21242408
[No Abstract] [Full Text] [Related]
26. Current treatment of nausea and vomiting associated with gastroparesis: antiemetics, prokinetics, tricyclics.
Stapleton J; Wo JM
Gastrointest Endosc Clin N Am; 2009 Jan; 19(1):57-72, vi. PubMed ID: 19232281
[TBL] [Abstract][Full Text] [Related]
27. A Simple Botulinum Toxin Injection Technique for Masseter Reduction.
Ng ZY; Yang T
Aesthet Surg J; 2021 Nov; 41(12):NP2104-NP2105. PubMed ID: 34223879
[No Abstract] [Full Text] [Related]
28. Botulinum toxin - neuropathic pain: Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial.
Br Dent J; 2016 Aug; 221(3):126. PubMed ID: 27514345
[TBL] [Abstract][Full Text] [Related]
29. Botulinum toxin for the treatment of gastroparesis: a preliminary report.
Lacy BE; Zayat EN; Crowell MD; Schuster MM
Am J Gastroenterol; 2002 Jun; 97(6):1548-52. PubMed ID: 12094882
[TBL] [Abstract][Full Text] [Related]
30. Addressing recent concerns in comparative studies of botulinum toxin type A.
de Boulle K; de Almeida AT
J Cosmet Laser Ther; 2010 Oct; 12(5):246-8. PubMed ID: 20825255
[No Abstract] [Full Text] [Related]
31. Treatment of gastroparesis with botulinum toxin in patient after allogenic bone marrow transplantation.
Galstyan GM; Pashkova MV; Popova OY; Makarova PM; Dubnyak DS; Kuzmina LA; Parovichnikova EN
Ter Arkh; 2018 Feb; 90(1):60-64. PubMed ID: 30701760
[TBL] [Abstract][Full Text] [Related]
32. Botulinum toxin products overview.
Carruthers A; Carruthers J
Skin Therapy Lett; 2008; 13(6):1-4. PubMed ID: 18806905
[TBL] [Abstract][Full Text] [Related]
33. Botulinum toxin. From poison to medical wonder.
Mayo Clin Health Lett; 2006 Dec; 24(12):4-5. PubMed ID: 17310508
[No Abstract] [Full Text] [Related]
34. [Gastroparesis--diagnosis and treatment].
Ciortescu I; Stanciu C
Rev Med Chir Soc Med Nat Iasi; 2009; 113(2):330-8. PubMed ID: 21495337
[TBL] [Abstract][Full Text] [Related]
35. [Treatment with botulinum toxin in neurologic pediatrics].
Justus N; Lee SH; Berweck S; Heinen F
Kinderkrankenschwester; 2007 Jul; 26(7):274-6. PubMed ID: 17726921
[No Abstract] [Full Text] [Related]
36. Management of antithrombotics for intramuscular injection of botulinum toxin for spasticity. A survey of real-life practice in France.
Ble O; Bensmail D; Pérennou D; Parratte B; Joseph PA; Boyer FC; Michelon H; Lansaman T; Levy J
Ann Phys Rehabil Med; 2021 Nov; 64(6):101467. PubMed ID: 33316432
[No Abstract] [Full Text] [Related]
37. The use of botulinum toxins to treat hyperhidrosis and gustatory sweating syndrome.
Glaser DA
Neurotox Res; 2006 Apr; 9(2-3):173-7. PubMed ID: 16785115
[TBL] [Abstract][Full Text] [Related]
38. Botox: beyond wrinkles.
Carruthers J; Carruthers A
Clin Dermatol; 2004; 22(1):89-93. PubMed ID: 15158551
[TBL] [Abstract][Full Text] [Related]
39. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
Pappert EJ; Germanson T;
Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274
[TBL] [Abstract][Full Text] [Related]
40. Safety of botulinum toxin therapies.
Madalinski MH; Slawek J
Dis Colon Rectum; 2003 Dec; 46(12):1719-20. PubMed ID: 14668605
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
